Amneal Pharmaceuticals, Inc. AMRX Other Operating Income Expense Net
Other Operating Income Expense Net at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s other operating income expense net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s other operating income expense net?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other operating income expense net of $6.94M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s other operating income expense net changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s other operating income expense net increased by 35.5% year-over-year, from $5.12M to $6.94M.